BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 18407790)

  • 21. Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16-year follow-up study.
    Alder S; Megyessi D; Sundström K; Östensson E; Mints M; Belkić K; Arbyn M; Andersson S
    Am J Obstet Gynecol; 2020 Feb; 222(2):172.e1-172.e12. PubMed ID: 31473226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical analysis of patients underwent hysterectomy for stage I cervical cancer or high grade cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia].
    He Y; Wu Y; Zhao Q; Fan B; Xu X; Zhu L; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):516-21. PubMed ID: 26311642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of a loop electrosurgical excision procedure for cervical intraepithelial neoplasia in a high incidence country.
    Sangkarat S; Ruengkhachorn I; Benjapibal M; Laiwejpithaya S; Wongthiraporn W; Rattanachaiyanont M
    Asian Pac J Cancer Prev; 2014; 15(2):1035-9. PubMed ID: 24568447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
    Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
    Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors for residual disease in the uterine cervix after large loop excision of the transformation zone in patients with cervical intraepithelial neoplasia III.
    Hamontri S; Israngura N; Rochanawutanon M; Bullangpoti S; Tangtrakul S
    J Med Assoc Thai; 2010 Feb; 93 Suppl 2():S74-80. PubMed ID: 21299083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term cumulative incidence of cervical intraepithelial neoplasia grade 3 or worse after abnormal cytology: impact of HIV infection.
    Massad LS; Pierce CB; Minkoff H; Watts DH; Darragh TM; Sanchez-Keeland L; Wright RL; Colie C; D'Souza G
    Int J Cancer; 2014 Apr; 134(8):1854-61. PubMed ID: 24170366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias.
    Sherman ME; Wang SS; Tarone R; Rich L; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):372-9. PubMed ID: 12692113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does colposcopically directed punch biopsy reduce the incidence of negative LLETZ?
    Denny LA; Soeters R; Dehaeck K; Bloch B
    Br J Obstet Gynaecol; 1995 Jul; 102(7):545-8. PubMed ID: 7647056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive cervical cancer after treatment of CIN.
    Herbert A; Culora G; McLean E; Kubba AA;
    J Am Soc Cytopathol; 2019; 8(6):324-332. PubMed ID: 31523013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical laser vaporization for women with cervical intraepithelial neoplasia-3.
    Shimada C; Todo Y; Yamazaki H; Minobe S; Kato H
    Jpn J Clin Oncol; 2019 May; 49(5):447-451. PubMed ID: 30796831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
    Hosaka M; Fujita H; Hanley SJ; Sasaki T; Shirakawa Y; Abiko M; Kudo M; Kaneuchi M; Watari H; Kikuchi K; Sakuragi N
    Int J Cancer; 2013 Jan; 132(2):327-34. PubMed ID: 22729477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The invasive potential of carcinoma in situ of the cervix.
    McIndoe WA; McLean MR; Jones RW; Mullins PR
    Obstet Gynecol; 1984 Oct; 64(4):451-8. PubMed ID: 6483293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study.
    Sand FL; Frederiksen K; Munk C; Jensen SM; Kjaer SK
    Int J Cancer; 2018 May; 142(9):1759-1766. PubMed ID: 29218720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subsequent risks for cervical precancer and cancer in women with low-grade squamous intraepithelial lesions unconfirmed by colposcopy-directed biopsy: results from a multicenter, prospective, cohort study.
    Matsumoto K; Hirai Y; Furuta R; Takatsuka N; Oki A; Yasugi T; Maeda H; Mitsuhashi A; Fujii T; Kawana K; Iwasaka T; Yaegashi N; Watanabe Y; Nagai Y; Kitagawa T; Yoshikawa H;
    Int J Clin Oncol; 2012 Jun; 17(3):233-9. PubMed ID: 21748261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.
    Gage JC; Hunt WC; Schiffman M; Katki HA; Cheung LC; Cuzick J; Myers O; Castle PE; Wheeler CM;
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):36-42. PubMed ID: 26518316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical glandular neoplasia referrals and the diagnosis of adenocarcinoma in situ: Correlating cytology, colposcopy findings, and clinical outcomes.
    Nikolopoulos M; Athanasias P; Godfrey MAL; Nikolopoulos K; Maheshwari MK
    Cytopathology; 2021 Nov; 32(6):751-757. PubMed ID: 34181788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.
    Macgregor JE; Campbell MK; Mann EM; Swanson KY
    BMJ; 1994 May; 308(6941):1407-11. PubMed ID: 8019250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.